APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

COX-2 Selective NSAIDs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global COX-2 Selective NSAIDs Industry Growth and Trends Forecast to 2032

Report ID 173981340128 December 202590 pages

Choose your research edition.

Industry ResearchCOX-2 Selective NSAIDs Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal COX-2 Selective NSAIDs Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal COX-2 Selective NSAIDs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal COX-2 Selective NSAIDs Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal COX-2 Selective NSAIDs Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global COX-2 Selective NSAIDs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for COX-2 Selective NSAIDs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for COX-2 Selective NSAIDs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for COX-2 Selective NSAIDs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of COX-2 Selective NSAIDs include Teva, Merck, Mylan, Jiangsu Hengrui Medicine, Pfizer, Lupin and Apotex, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global COX-2 Selective NSAIDs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The COX-2 Selective NSAIDs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global COX-2 Selective NSAIDs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to COX-2 Selective NSAIDs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global COX-2 Selective NSAIDs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

COX-2 Selective NSAIDs Market by Company

Teva

Merck

Mylan

Jiangsu Hengrui Medicine

Pfizer

Lupin

Apotex

COX-2 Selective NSAIDs Segment by Type

Valdecoxib

Rofecoxib

Celecoxib

Etoricoxib

COX-2 Selective NSAIDs Segment by Application

Hospital

Clinic

Other

COX-2 Selective NSAIDs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global COX-2 Selective NSAIDs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of COX-2 Selective NSAIDs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of COX-2 Selective NSAIDs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of COX-2 Selective NSAIDs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of COX-2 Selective NSAIDs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Valdecoxib Table 2. Major Company of Rofecoxib Table 3. Major Company of Celecoxib Table 4. Major Company of Etoricoxib Table 5. Global COX-2 Selective NSAIDs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global COX-2 Selective NSAIDs Sales by Type (2021-2026) & (K Units) Table 7. Global COX-2 Selective NSAIDs Sales Market Share in Volume by Type (2021-2026) Table 8. Global COX-2 Selective NSAIDs Sales by Type (2021-2026) & (US$ Million) Table 9. Global COX-2 Selective NSAIDs Sales Market Share in Value by Type (2021-2026) Table 10. Global COX-2 Selective NSAIDs Price by Type (2021-2026) & (US$/Unit) Table 11. Global COX-2 Selective NSAIDs Sales by Type (2027-2032) & (K Units) Table 12. Global COX-2 Selective NSAIDs Sales Market Share in Volume by Type (2027-2032) Table 13. Global COX-2 Selective NSAIDs Sales by Type (2027-2032) & (US$ Million) Table 14. Global COX-2 Selective NSAIDs Sales Market Share in Value by Type (2027-2032) Table 15. Global COX-2 Selective NSAIDs Price by Type (2027-2032) & (US$/Unit) Table 16. North America COX-2 Selective NSAIDs Sales by Type (2021-2026) & (K Units) Table 17. North America COX-2 Selective NSAIDs Sales by Type (2021-2026) & (US$ Million) Table 18. Europe COX-2 Selective NSAIDs Sales by Type (2021-2026) & (K Units) Table 19. Europe COX-2 Selective NSAIDs Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific COX-2 Selective NSAIDs Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific COX-2 Selective NSAIDs Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America COX-2 Selective NSAIDs Sales by Type (2021-2026) & (K Units) Table 23. Latin America COX-2 Selective NSAIDs Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa COX-2 Selective NSAIDs Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa COX-2 Selective NSAIDs Sales by Type (2021-2026) & (US$ Million) Table 26. COX-2 Selective NSAIDs Industry Trends Table 27. COX-2 Selective NSAIDs Industry Drivers Table 28. COX-2 Selective NSAIDs Industry Opportunities and Challenges Table 29. COX-2 Selective NSAIDs Industry Restraints Table 30. Global COX-2 Selective NSAIDs Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global COX-2 Selective NSAIDs Revenue Market Share by Company (2021-2026) Table 32. Global COX-2 Selective NSAIDs Sales by Company (2021-2026) & (K Units) Table 33. Global COX-2 Selective NSAIDs Sales Share by Company (2021-2026) Table 34. Global COX-2 Selective NSAIDs Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global COX-2 Selective NSAIDs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global COX-2 Selective NSAIDs Major Company Production Sites and Headquarters Table 37. Global COX-2 Selective NSAIDs Company, Product Type & Application Table 38. Global COX-2 Selective NSAIDs Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global COX-2 Selective NSAIDs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global COX-2 Selective NSAIDs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global COX-2 Selective NSAIDs Sales by Region (2021-2026) & (K Units) Table 43. Global COX-2 Selective NSAIDs Sales Market Share in Volume by Region (2021-2026) Table 44. Global COX-2 Selective NSAIDs Sales by Region (2021-2026) & (US$ Million) Table 45. Global COX-2 Selective NSAIDs Sales Market Share in Value by Region (2021-2026) Table 46. Global COX-2 Selective NSAIDs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global COX-2 Selective NSAIDs Sales by Region (2027-2032) & (K Units) Table 48. Global COX-2 Selective NSAIDs Sales Market Share in Volume by Region (2027-2032) Table 49. Global COX-2 Selective NSAIDs Sales by Region (2027-2032) & (US$ Million) Table 50. Global COX-2 Selective NSAIDs Sales Market Share in Value by Region (2027-2032) Table 51. Global COX-2 Selective NSAIDs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global COX-2 Selective NSAIDs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global COX-2 Selective NSAIDs Sales by Application (2021-2026) & (K Units) Table 54. Global COX-2 Selective NSAIDs Sales Market Share in Volume by Application (2021-2026) Table 55. Global COX-2 Selective NSAIDs Sales by Application (2021-2026) & (US$ Million) Table 56. Global COX-2 Selective NSAIDs Sales Market Share in Value by Application (2021-2026) Table 57. Global COX-2 Selective NSAIDs Price by Application (2021-2026) & (US$/Unit) Table 58. Global COX-2 Selective NSAIDs Sales by Application (2027-2032) & (K Units) Table 59. Global COX-2 Selective NSAIDs Sales Market Share in Volume by Application (2027-2032) Table 60. Global COX-2 Selective NSAIDs Sales by Application (2027-2032) & (US$ Million) Table 61. Global COX-2 Selective NSAIDs Sales Market Share in Value by Application (2027-2032) Table 62. Global COX-2 Selective NSAIDs Price by Application (2027-2032) & (US$/Unit) Table 63. North America COX-2 Selective NSAIDs Sales by Application (2021-2026) & (K Units) Table 64. North America COX-2 Selective NSAIDs Sales by Application (2021-2026) & (US$ Million) Table 65. Europe COX-2 Selective NSAIDs Sales by Application (2021-2026) & (K Units) Table 66. Europe COX-2 Selective NSAIDs Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific COX-2 Selective NSAIDs Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific COX-2 Selective NSAIDs Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America COX-2 Selective NSAIDs Sales by Application (2021-2026) & (K Units) Table 70. Latin America COX-2 Selective NSAIDs Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa COX-2 Selective NSAIDs Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa COX-2 Selective NSAIDs Sales by Application (2021-2026) & (US$ Million) Table 73. Teva Company Information Table 74. Teva Business Overview Table 75. Teva COX-2 Selective NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Teva COX-2 Selective NSAIDs Product Portfolio Table 77. Teva Recent Development Table 78. Merck Company Information Table 79. Merck Business Overview Table 80. Merck COX-2 Selective NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Merck COX-2 Selective NSAIDs Product Portfolio Table 82. Merck Recent Development Table 83. Mylan Company Information Table 84. Mylan Business Overview Table 85. Mylan COX-2 Selective NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Mylan COX-2 Selective NSAIDs Product Portfolio Table 87. Mylan Recent Development Table 88. Jiangsu Hengrui Medicine Company Information Table 89. Jiangsu Hengrui Medicine Business Overview Table 90. Jiangsu Hengrui Medicine COX-2 Selective NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Jiangsu Hengrui Medicine COX-2 Selective NSAIDs Product Portfolio Table 92. Jiangsu Hengrui Medicine Recent Development Table 93. Pfizer Company Information Table 94. Pfizer Business Overview Table 95. Pfizer COX-2 Selective NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Pfizer COX-2 Selective NSAIDs Product Portfolio Table 97. Pfizer Recent Development Table 98. Lupin Company Information Table 99. Lupin Business Overview Table 100. Lupin COX-2 Selective NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Lupin COX-2 Selective NSAIDs Product Portfolio Table 102. Lupin Recent Development Table 103. Apotex Company Information Table 104. Apotex Business Overview Table 105. Apotex COX-2 Selective NSAIDs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Apotex COX-2 Selective NSAIDs Product Portfolio Table 107. Apotex Recent Development Table 108. North America COX-2 Selective NSAIDs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 109. North America COX-2 Selective NSAIDs Sales by Country (2021-2026) & (K Units) Table 110. North America COX-2 Selective NSAIDs Sales Market Share by Country (2021-2026) Table 111. North America COX-2 Selective NSAIDs Sales Forecast by Country (2027-2032) & (K Units) Table 112. North America COX-2 Selective NSAIDs Sales Market Share Forecast by Country (2027-2032) Table 113. North America COX-2 Selective NSAIDs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. North America COX-2 Selective NSAIDs Market Size by Country (2021-2026) & (US$ Million) Table 115. North America COX-2 Selective NSAIDs Market Share by Country (2021-2026) Table 116. North America COX-2 Selective NSAIDs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. North America COX-2 Selective NSAIDs Market Share Forecast by Country (2027-2032) Table 118. Europe COX-2 Selective NSAIDs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 119. Europe COX-2 Selective NSAIDs Sales by Country (2021-2026) & (K Units) Table 120. Europe COX-2 Selective NSAIDs Sales Market Share by Country (2021-2026) Table 121. Europe COX-2 Selective NSAIDs Sales Forecast by Country (2027-2032) & (K Units) Table 122. Europe COX-2 Selective NSAIDs Sales Market Share Forecast by Country (2027-2032) Table 123. Europe COX-2 Selective NSAIDs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Europe COX-2 Selective NSAIDs Market Size by Country (2021-2026) & (US$ Million) Table 125. Europe COX-2 Selective NSAIDs Market Share by Country (2021-2026) Table 126. Europe COX-2 Selective NSAIDs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Europe COX-2 Selective NSAIDs Market Share Forecast by Country (2027-2032) Table 128. Asia-Pacific COX-2 Selective NSAIDs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 129. Asia-Pacific COX-2 Selective NSAIDs Sales by Country (2021-2026) & (K Units) Table 130. Asia-Pacific COX-2 Selective NSAIDs Sales Market Share by Country (2021-2026) Table 131. Asia-Pacific COX-2 Selective NSAIDs Sales Forecast by Country (2027-2032) & (K Units) Table 132. Asia-Pacific COX-2 Selective NSAIDs Sales Market Share Forecast by Country (2027-2032) Table 133. Asia-Pacific COX-2 Selective NSAIDs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Asia-Pacific COX-2 Selective NSAIDs Market Size by Country (2021-2026) & (US$ Million) Table 135. Asia-Pacific COX-2 Selective NSAIDs Market Share by Country (2021-2026) Table 136. Asia-Pacific COX-2 Selective NSAIDs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Asia-Pacific COX-2 Selective NSAIDs Market Share Forecast by Country (2027-2032) Table 138. Latin America COX-2 Selective NSAIDs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 139. Latin America COX-2 Selective NSAIDs Sales by Country (2021-2026) & (K Units) Table 140. Latin America COX-2 Selective NSAIDs Sales Market Share by Country (2021-2026) Table 141. Latin America COX-2 Selective NSAIDs Sales Forecast by Country (2027-2032) & (K Units) Table 142. Latin America COX-2 Selective NSAIDs Sales Market Share Forecast by Country (2027-2032) Table 143. Latin America COX-2 Selective NSAIDs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Latin America COX-2 Selective NSAIDs Market Size by Country (2021-2026) & (US$ Million) Table 145. Latin America COX-2 Selective NSAIDs Market Share by Country (2021-2026) Table 146. Latin America COX-2 Selective NSAIDs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Latin America COX-2 Selective NSAIDs Market Share Forecast by Country (2027-2032) Table 148. Middle East and Africa COX-2 Selective NSAIDs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 149. Middle East and Africa COX-2 Selective NSAIDs Sales by Country (2021-2026) & (K Units) Table 150. Middle East and Africa COX-2 Selective NSAIDs Sales Market Share by Country (2021-2026) Table 151. Middle East and Africa COX-2 Selective NSAIDs Sales Forecast by Country (2027-2032) & (K Units) Table 152. Middle East and Africa COX-2 Selective NSAIDs Sales Market Share Forecast by Country (2027-2032) Table 153. Middle East and Africa COX-2 Selective NSAIDs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Middle East and Africa COX-2 Selective NSAIDs Market Size by Country (2021-2026) & (US$ Million) Table 155. Middle East and Africa COX-2 Selective NSAIDs Market Share by Country (2021-2026) Table 156. Middle East and Africa COX-2 Selective NSAIDs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Middle East and Africa COX-2 Selective NSAIDs Market Share Forecast by Country (2027-2032) Table 158. Key Raw Materials Table 159. Raw Materials Key Suppliers Table 160. COX-2 Selective NSAIDs Distributors List Table 161. COX-2 Selective NSAIDs Customers List Table 162. Research Programs/Design for This Report Table 163. Authors List of This Report Table 164. Secondary Sources Table 165. Primary Sources List of Figures Figure 1. COX-2 Selective NSAIDs Image Figure 2. Global COX-2 Selective NSAIDs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global COX-2 Selective NSAIDs Market Size (2021-2032) & (US$ Million) Figure 4. Global COX-2 Selective NSAIDs Sales (2021-2032) & (K Units) Figure 5. Valdecoxib Image Figure 6. Global Valdecoxib Sales YoY Growth (2021-2032) & (K Units) Figure 7. Rofecoxib Image Figure 8. Global Rofecoxib Sales YoY Growth (2021-2032) & (K Units) Figure 9. Celecoxib Image Figure 10. Global Celecoxib Sales YoY Growth (2021-2032) & (K Units) Figure 11. Etoricoxib Image Figure 12. Global Etoricoxib Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global COX-2 Selective NSAIDs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global COX-2 Selective NSAIDs Market Share by Type 2025 VS 2032 Figure 15. North America COX-2 Selective NSAIDs Sales Market Share in Volume by Type in 2025 Figure 16. North America COX-2 Selective NSAIDs Sales Market Share in Value by Type in 2025 Figure 17. Europe COX-2 Selective NSAIDs Sales Market Share in Volume by Type in 2025 Figure 18. Europe COX-2 Selective NSAIDs Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific COX-2 Selective NSAIDs Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific COX-2 Selective NSAIDs Sales Market Share in Value by Type in 2025 Figure 21. Latin America COX-2 Selective NSAIDs Sales Market Share in Volume by Type in 2025 Figure 22. Latin America COX-2 Selective NSAIDs Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa COX-2 Selective NSAIDs Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa COX-2 Selective NSAIDs Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 COX-2 Selective NSAIDs Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Hospital Image Figure 28. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 29. Clinic Image Figure 30. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 31. Other Image Figure 32. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global COX-2 Selective NSAIDs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global COX-2 Selective NSAIDs Market Share by Application 2025 VS 2032 Figure 35. North America COX-2 Selective NSAIDs Sales Market Share in Volume by Application in 2025 Figure 36. North America COX-2 Selective NSAIDs Sales Market Share in Value by Application in 2025 Figure 37. Europe COX-2 Selective NSAIDs Sales Market Share in Volume by Application in 2025 Figure 38. Europe COX-2 Selective NSAIDs Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific COX-2 Selective NSAIDs Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific COX-2 Selective NSAIDs Sales Market Share in Value by Application in 2025 Figure 41. Latin America COX-2 Selective NSAIDs Sales Market Share in Volume by Application in 2025 Figure 42. Latin America COX-2 Selective NSAIDs Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa COX-2 Selective NSAIDs Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa COX-2 Selective NSAIDs Sales Market Share in Value by Application in 2025 Figure 45. North America COX-2 Selective NSAIDs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America COX-2 Selective NSAIDs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America COX-2 Selective NSAIDs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America COX-2 Selective NSAIDs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe COX-2 Selective NSAIDs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe COX-2 Selective NSAIDs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe COX-2 Selective NSAIDs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe COX-2 Selective NSAIDs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific COX-2 Selective NSAIDs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific COX-2 Selective NSAIDs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific COX-2 Selective NSAIDs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific COX-2 Selective NSAIDs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America COX-2 Selective NSAIDs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America COX-2 Selective NSAIDs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America COX-2 Selective NSAIDs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America COX-2 Selective NSAIDs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa COX-2 Selective NSAIDs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa COX-2 Selective NSAIDs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa COX-2 Selective NSAIDs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa COX-2 Selective NSAIDs Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. COX-2 Selective NSAIDs Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. COX-2 Selective NSAIDs Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Valdecoxib
  • Rofecoxib
  • Celecoxib
  • Etoricoxib
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Teva
  • Merck
  • Mylan
  • Jiangsu Hengrui Medicine
  • Pfizer
  • Lupin
  • Apotex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global COX-2 Selective NSAIDs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global COX-2 Selective NSAIDs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 COX-2 Selective NSAIDs Market by Type
  6. 1.3.1 Valdecoxib
  7. 1.3.2 Rofecoxib
  8. 1.3.3 Celecoxib
  9. 1.3.4 Etoricoxib
  10. 1.4 Global COX-2 Selective NSAIDs Market Size by Type
  11. 1.4.1 Global COX-2 Selective NSAIDs Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global COX-2 Selective NSAIDs Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global COX-2 Selective NSAIDs Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America COX-2 Selective NSAIDs Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe COX-2 Selective NSAIDs Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific COX-2 Selective NSAIDs Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America COX-2 Selective NSAIDs Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa COX-2 Selective NSAIDs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 COX-2 Selective NSAIDs Industry Trends
  2. 2.2 COX-2 Selective NSAIDs Industry Drivers
  3. 2.3 COX-2 Selective NSAIDs Industry Opportunities and Challenges
  4. 2.4 COX-2 Selective NSAIDs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by COX-2 Selective NSAIDs Revenue (2021-2026)
  2. 3.2 Global Top Players by COX-2 Selective NSAIDs Sales (2021-2026)
  3. 3.3 Global Top Players by COX-2 Selective NSAIDs Price (2021-2026)
  4. 3.4 Global COX-2 Selective NSAIDs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global COX-2 Selective NSAIDs Major Company Production Sites & Headquarters
  6. 3.6 Global COX-2 Selective NSAIDs Company, Product Type & Application
  7. 3.7 Global COX-2 Selective NSAIDs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global COX-2 Selective NSAIDs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 COX-2 Selective NSAIDs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 COX-2 Selective NSAIDs Tier 1, Tier 2, and Tier 3
4 COX-2 Selective NSAIDs Regional Status and Outlook
  1. 4.1 Global COX-2 Selective NSAIDs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global COX-2 Selective NSAIDs Historic Market Size by Region
  3. 4.2.1 Global COX-2 Selective NSAIDs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global COX-2 Selective NSAIDs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global COX-2 Selective NSAIDs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global COX-2 Selective NSAIDs Forecasted Market Size by Region
  7. 4.3.1 Global COX-2 Selective NSAIDs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global COX-2 Selective NSAIDs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global COX-2 Selective NSAIDs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 COX-2 Selective NSAIDs by Application
  1. 5.1 COX-2 Selective NSAIDs Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global COX-2 Selective NSAIDs Market Size by Application
  6. 5.2.1 Global COX-2 Selective NSAIDs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global COX-2 Selective NSAIDs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global COX-2 Selective NSAIDs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America COX-2 Selective NSAIDs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe COX-2 Selective NSAIDs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific COX-2 Selective NSAIDs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America COX-2 Selective NSAIDs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa COX-2 Selective NSAIDs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva COX-2 Selective NSAIDs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva COX-2 Selective NSAIDs Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 Merck
  8. 6.2.1 Merck Company Information
  9. 6.2.2 Merck Business Overview
  10. 6.2.3 Merck COX-2 Selective NSAIDs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Merck COX-2 Selective NSAIDs Product Portfolio
  12. 6.2.5 Merck Recent Developments
  13. 6.3 Mylan
  14. 6.3.1 Mylan Company Information
  15. 6.3.2 Mylan Business Overview
  16. 6.3.3 Mylan COX-2 Selective NSAIDs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Mylan COX-2 Selective NSAIDs Product Portfolio
  18. 6.3.5 Mylan Recent Developments
  19. 6.4 Jiangsu Hengrui Medicine
  20. 6.4.1 Jiangsu Hengrui Medicine Company Information
  21. 6.4.2 Jiangsu Hengrui Medicine Business Overview
  22. 6.4.3 Jiangsu Hengrui Medicine COX-2 Selective NSAIDs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Jiangsu Hengrui Medicine COX-2 Selective NSAIDs Product Portfolio
  24. 6.4.5 Jiangsu Hengrui Medicine Recent Developments
  25. 6.5 Pfizer
  26. 6.5.1 Pfizer Company Information
  27. 6.5.2 Pfizer Business Overview
  28. 6.5.3 Pfizer COX-2 Selective NSAIDs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Pfizer COX-2 Selective NSAIDs Product Portfolio
  30. 6.5.5 Pfizer Recent Developments
  31. 6.6 Lupin
  32. 6.6.1 Lupin Company Information
  33. 6.6.2 Lupin Business Overview
  34. 6.6.3 Lupin COX-2 Selective NSAIDs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Lupin COX-2 Selective NSAIDs Product Portfolio
  36. 6.6.5 Lupin Recent Developments
  37. 6.7 Apotex
  38. 6.7.1 Apotex Company Information
  39. 6.7.2 Apotex Business Overview
  40. 6.7.3 Apotex COX-2 Selective NSAIDs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Apotex COX-2 Selective NSAIDs Product Portfolio
  42. 6.7.5 Apotex Recent Developments
7 North America by Country
  1. 7.1 North America COX-2 Selective NSAIDs Sales by Country
  2. 7.1.1 North America COX-2 Selective NSAIDs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America COX-2 Selective NSAIDs Sales by Country (2021-2026)
  4. 7.1.3 North America COX-2 Selective NSAIDs Sales Forecast by Country (2027-2032)
  5. 7.2 North America COX-2 Selective NSAIDs Market Size by Country
  6. 7.2.1 North America COX-2 Selective NSAIDs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America COX-2 Selective NSAIDs Market Size by Country (2021-2026)
  8. 7.2.3 North America COX-2 Selective NSAIDs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe COX-2 Selective NSAIDs Sales by Country
  2. 8.1.1 Europe COX-2 Selective NSAIDs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe COX-2 Selective NSAIDs Sales by Country (2021-2026)
  4. 8.1.3 Europe COX-2 Selective NSAIDs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe COX-2 Selective NSAIDs Market Size by Country
  6. 8.2.1 Europe COX-2 Selective NSAIDs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe COX-2 Selective NSAIDs Market Size by Country (2021-2026)
  8. 8.2.3 Europe COX-2 Selective NSAIDs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific COX-2 Selective NSAIDs Sales by Country
  2. 9.1.1 Asia-Pacific COX-2 Selective NSAIDs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific COX-2 Selective NSAIDs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific COX-2 Selective NSAIDs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific COX-2 Selective NSAIDs Market Size by Country
  6. 9.2.1 Asia-Pacific COX-2 Selective NSAIDs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific COX-2 Selective NSAIDs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific COX-2 Selective NSAIDs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America COX-2 Selective NSAIDs Sales by Country
  2. 10.1.1 South America COX-2 Selective NSAIDs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America COX-2 Selective NSAIDs Sales by Country (2021-2026)
  4. 10.1.3 South America COX-2 Selective NSAIDs Sales Forecast by Country (2027-2032)
  5. 10.2 South America COX-2 Selective NSAIDs Market Size by Country
  6. 10.2.1 South America COX-2 Selective NSAIDs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America COX-2 Selective NSAIDs Market Size by Country (2021-2026)
  8. 10.2.3 South America COX-2 Selective NSAIDs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa COX-2 Selective NSAIDs Sales by Country
  2. 11.1.1 Middle East and Africa COX-2 Selective NSAIDs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa COX-2 Selective NSAIDs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa COX-2 Selective NSAIDs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa COX-2 Selective NSAIDs Market Size by Country
  6. 11.2.1 Middle East and Africa COX-2 Selective NSAIDs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa COX-2 Selective NSAIDs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa COX-2 Selective NSAIDs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 COX-2 Selective NSAIDs Value Chain Analysis
  2. 12.1.1 COX-2 Selective NSAIDs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 COX-2 Selective NSAIDs Production Mode & Process
  7. 12.2 COX-2 Selective NSAIDs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 COX-2 Selective NSAIDs Distributors
  10. 12.2.3 COX-2 Selective NSAIDs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst